V. I. Références,

L. C. Zingale, L. Beltrami, A. Zanichelli, L. Maggioni, E. Pappalardo et al., Angioedema without urticaria: a large clinical survey, Canadian Medical Association Journal, vol.175, issue.9, pp.1065-1070, 2006.

M. Mansi, A. Zanichelli, A. Coerezza, C. Suffritti, M. A. Wu et al.,

, Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients, J Intern Med, vol.277, pp.585-93, 2015.

I. Boccon-gibod and L. Bouillet, Les angioedèmes dans l'urticaire, Annales de dermatologie et de vénéréologie, vol.141, pp.586-595, 2014.

J. Crochet, Angioedèmes histaminiques versus bradykiniques : mortalité par asphyxie. Médecine humaine et pathologie, 2017.

H. Makani, F. H. Messerli, J. Romero, O. Wever-pinzon, A. Korniyenko et al., Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors, American Journal of Cardiology, vol.110, issue.3, pp.383-391, 2012.

L. Bouillet, L'angioedème laryngé induit par les médicaments interférant avec le métabolisme de la bradykinine, Revue Française d'Allergologie, vol.52, issue.3, pp.157-159, 2012.

T. Brown, J. Gonzalez, and C. Monteleone, Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature, The Journal of Clinical Hypertension, vol.19, issue.12, pp.1377-1382, 2017.

R. E. Owens and C. S. Oliphant, Angioedema spotlight: a closer examination of sacubitril/valsartan safety results, The Journal of the American Board of Family Medicine, vol.30, issue.4, pp.556-557, 2017.

I. M. Otani and A. Banerji, Acquired C1 Inhibitor Deficiency, Immunology and Allergy Clinics, vol.37, issue.3, pp.497-511, 2017.

M. Cicardi and B. L. Zuraw, Angioedema due to bradykinin dysregulation, 2018.

, The Journal of Allergy and Clinical Immunology: In Practice, vol.6, issue.4, pp.1132-1141

S. G. Chiappe, L. Bouillet, O. Fain, A. Gompel, L. Guis et al.,

L. Weiss, Prévalence de l'angioedème héréditaire de types 1 et 2 à Paris en 2016 (étude EPI-AOH75). La Revue de Médecine Interne, vol.39, pp.110-111, 2018.

O. Roche, A. Blanch, T. Caballero, N. Sastre, D. Callejo et al.,

M. , Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain, Asthma & Immunology, vol.94, issue.4, pp.498-503, 2005.

G. Dewald and K. Bork, Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor, Biochem Biophys Res Commun, vol.343, pp.1286-1295, 2006.

J. Bjorkqvist, S. De-maat, U. Lewandrowski, D. Gennaro, A. Oschatz et al., Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III, J Clin Invest, vol.125, pp.3132-3178, 2015.

S. De-maat, J. Bjorkqvist, C. Suffritti, C. P. Wiesenekker, W. Nagtegaal et al., Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations, J Allergy Clin Immunol, vol.138, pp.1414-1437, 2016.

K. Bork, K. Wulff, L. Steinmuller-magin, I. Braenne, P. Staubach-renz et al., Hereditary angioedema with a mutation in the plasminogen gene, Allergy, vol.73, pp.442-50, 2018.

V. Bafunno, D. Firinu, D. 'apolito, M. Cordisco, G. Loffredo et al., Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema, J Allergy Clin Immunol, vol.141, pp.1009-1026, 2018.

M. Cicardi, W. Aberer, A. Banerji, M. Bas, J. A. Bernstein et al.,

M. A. , Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group, Allergy, vol.69, issue.5, pp.602-616, 2014.

M. Maurer, M. Magerl, I. Ansotegui, E. Aygören-pürsün, S. Betschel et al., The international WAO/EAACI guideline for the management of hereditary angioedema-the 2017 revision and update, World Allergy Organization Journal, vol.11, issue.1, p.5, 2018.

T. J. Craig, J. A. Bernstein, H. Farkas, L. Bouillet, and I. Boccon-gibod, , 2014.

, Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting. International archives of allergy and immunology, vol.165, pp.119-127

C. James and J. A. Bernstein, Current and future therapies for the treatment of histamine-induced angioedema, Expert opinion on pharmacotherapy, vol.18, issue.3, pp.253-262, 2017.

E. R. Rasmussen, P. V. De-freitas, and A. Bygum, Urticaria and Prodromal Symptoms Including Erythema Marginatum in Danish Patients with Hereditary Angioedema, Acta Derm Venereol, vol.96, issue.3, pp.373-379, 2016.

, Recommandations d'utilisation des inhibiteurs de la C1 estérase humaine (Cinryze et Berinert) en période de tensions d'approvisionnement-Point

I. M. Otani, S. C. Christiansen, and P. Busse, Emergency department management of hereditary angioedema attacks: patient perspectives, J Allergy Clin Immunol Pract, vol.5, pp.128-134, 2016.

M. Cicardi, L. C. Zingale, L. Bergamaschini, and A. Agostoni, Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment, Archives of internal medicine, vol.164, issue.8, pp.910-913, 2004.

C. Faisant, I. Boccon-gibod, C. Mansard, C. Dumestre-perard, and P. Pralong,

C. Chatain, .. .. Bouillet, and L. , Idiopathic histaminergic angioedema without wheals: a case series of 31 patients, Clinical & Experimental Immunology, vol.185, issue.1, pp.81-85, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02180372

J. F. Nicolas, Au-delà de l'histamine, la physiopathologie de l'urticaire, Annales de Dermatologie et de Vénéréologie, vol.136, pp.8-10, 2009.